Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Linde India Limited (LINDEINDIA.NS)
Kolkata, IN
Linde India Limited is a leading industrial gases enterprise operating within India. Its business is structured into two principal divisions: Gases and Related Products, and Project Engineering. The Gases and Related Products segment primarily manufactures and distributes essential industrial gases such as oxygen, nitrogen, and argon. Its supply channels include pipeline delivery to heavy industries like steel, glass, and chemical manufacturing; liquefied gas transport in cryogenic tankers for a variety of industrial applications; and compressed gas in cylinders for the fabrication, manufacturing, and construction sectors. Additionally, this division caters to the healthcare industry, offering medical gases like oxygen, synthetic air, and nitrous oxide for pharmaceutical use, alongside providing comprehensive medical gas distribution systems for hospitals. The Project Engineering division specializes in the end-to-end execution of air separation plants and related turnkey projects. This encompasses everything from design and engineering to supply, installation, testing, and commissioning. This segment also fabricates a diverse range of specialized components, including distillation columns for air separation, cryogenic liquid storage tanks, ambient and steam bath vaporizers, process vessels, LINIT plants, small-sized cold boxes, and containerized micro plants for cylinder filling, serving both internal requirements and external clients. Beyond these core offerings, the company supplies a broad spectrum of gases and mixtures, complemented by extensive related services such as the construction and installation of plants, equipment, and pipelines, along with associated engineering services for various industries. Founded in 1935 and headquartered in Kolkata, India, the company rebranded as Linde India Limited in February 2013, having previously operated as BOC India Limited. It functions as a subsidiary of The BOC Group Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.95% | -3.20% | -1.78% | +6.84% | +20.52% | +20.73% | -4.39% | +81.74% | +349.77% | +2,477.52% | +3,934.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+1.8% Q1'26: +3.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+20.7% ★ Q1'26: -34.6% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+21.5% Q1'26: +8.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+26.6% ★ Q1'26: +18.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+11.9% ★ Q1'26: +7.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.09× ★ Q1'26: 0.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 3 Rev. Ana. 2 EPS Ana. |
Mar 2027 3 Rev. Ana. 3 EPS Ana. |
Mar 2028 3 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
25.05B
est: 28.51B (-12.1%)
|
27.68B
est: 28.89B (-4.2%)
|
24.85B
est: 26.71B (-7.0%)
|
26.23B
26.11B – 26.30B
-1.8% YoY
|
29.62B
25.43B – 36.68B
+12.9% YoY
|
34.13B
29.13B – 43.09B
+15.2% YoY
|
| EBITDA |
6.84B
est: 7.98B (-14.2%)
|
7.87B
est: 10.81B (-27.2%)
|
8.40B
est: 8.51B (-1.3%)
|
8.35B
8.32B – 8.38B
-1.8% YoY
|
9.43B
8.10B – 11.68B
+12.9% YoY
|
10.87B
9.28B – 13.72B
+15.2% YoY
|
| EBIT |
4.82B
est: 5.46B (-11.8%)
|
5.86B
est: 9.31B (-37.1%)
|
6.26B
est: 7.39B (-15.3%)
|
7.25B
7.22B – 7.27B
-1.8% YoY
|
8.19B
7.03B – 10.15B
+12.9% YoY
|
9.44B
8.06B – 11.92B
+15.2% YoY
|
| Net Income |
4.39B
est: 6.03B (-27.2%)
|
4.34B
est: 6.43B (-32.5%)
|
4.55B
est: 5.74B (-20.8%)
|
5.64B
5.62B – 5.66B
-1.8% YoY
|
6.11B
5.34B – 7.58B
+8.2% YoY
|
7.43B
6.39B – 9.40B
+21.6% YoY
|
| SGA |
231.89M
est: 1.52B (-84.8%)
|
544.63M
est: 1.54B (-64.7%)
|
564.78M
est: 661.55M (-14.6%)
|
649.51M
646.67M – 651.32M
-1.8% YoY
|
733.49M
629.82M – 908.51M
+12.9% YoY
|
845.21M
721.46M – 1.07B
+15.2% YoY
|
| EPS |
51.45
est: 70.70 (-27.2%)
|
50.90
est: 75.40 (-32.5%)
|
53.33
est: 67.35 (-20.8%)
|
66.15
65.90 – 66.40
-1.8% YoY
|
71.60
62.63 – 88.84
+8.2% YoY
|
87.10
74.87 – 110.18
+21.6% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Emerging Markets Ex-China ETF VEXC | 0.02% | 42.7K | 0.07% |
| 2 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing VDEM.L | 0.01% | 792.0K | 0.17% |
| 3 | Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating VFEA.L | 0.01% | 792.0K | 0.17% |
| 4 | Schwab Emerging Markets Equity ETF SCHE | 0.01% | 1.74M | 0.06% |
| 5 | Vanguard FTSE Asia ex Japan Shares Index ETF VAE.AX | 0.01% | 77.5K | 0.40% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.01% | 382.0K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.01% | 169.3K | 0.48% |
| 8 | Vanguard FTSE Emerging Markets ETF VWO | 0.01% | 18.85M | 0.06% |
| 9 | Vanguard ESG International Stock ETF VSGX | 0.00% | 307.3K | 0.10% |
| 10 | Vanguard All-World ex-US Shares Index ETF VEU.AX | 0.00% | 149.2K | 0.04% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Milan Sadhukhan | MD & Executive Director | 6M | male |
| Ajay Kumar Sah | Interim Chief Financial Officer | — | male |
| Amit Dhanuka | Company Secretary & Compliance Officer | — | male |
| Arabinda Adhikari | Head of Project Engineering Division | — | male |
| Shobhit Sinha | Head of Corporate Communications | — | — |
| Sneha Bajpai | Head of HR & Administration | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for LINDEINDIA.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
